Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery

Inclusion Criteria: * ≥18 to ≤ 70 years of age at time of consent * Subject scheduled to undergo bilateral endoscopic sinus surgery * Able to speak, read and understand English * Willing and able to provide informed consent and comply with the study protocol Exclusion Criteria: * History of removal of one or both middle turbinates * Presence of significant concha bullosa, which requires surgical excision * Presence of non-viable tissue at the implantation site * Active infection at the implantation site * Chronic nasal decongestant use (i.e. Afrin, etc) * Recreational intra-nasal drug use within 12 months of enrollment * Documented evidence of a history (e.g., liver testing) of drug/alcohol abuse within 12 months of enrollment * Hypersensitivity to any investigational device materials including known or suspected allergy to poly(dioxanone) (PDO) or other bioabsorbable materials